Aprea Therapeutics, Inc. ( APRE) - Key Metrics
APRE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.07 | -$0.06 | -$0.06 |
| 2026Q1 | $0 | -$0.43 | -$0.36 | -$0.36 |
| 2025Q4 | $0 | -$0.32 | -$0.39 | -$0.39 |
| 2025Q3 | $0 | -$0.47 | -$0.50 | -$0.50 |
| 2025Q2 | $0.02 | -$0.53 | -$0.51 | -$0.51 |
APRE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.87 |
| 2026Q1 | 0% | -0.44 |
| 2025Q4 | 0% | -0.67 |
| 2025Q3 | 0% | -0.79 |
| 2025Q2 | 0% | -0.80 |
APRE
Price: $0.60
52 week price:
Earnings Per Share: -1.49 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 118567
Market Capitalization: 8.6 million